BLACKROCK ADVISORS LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 123 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,247,000
+5.4%
37,209
-16.3%
0.00%0.0%
Q3 2016$1,183,000
+18.1%
44,464
-2.2%
0.00%0.0%
Q2 2016$1,002,000
-32.5%
45,457
-10.0%
0.00%
-50.0%
Q1 2016$1,484,000
-0.4%
50,519
+12.0%
0.00%0.0%
Q4 2015$1,490,000
-22.7%
45,112
-15.5%
0.00%0.0%
Q3 2015$1,928,000
-23.1%
53,358
-4.3%
0.00%
-33.3%
Q2 2015$2,508,000
-3.8%
55,751
-34.5%
0.00%0.0%
Q1 2015$2,606,000
-11.0%
85,104
+47.8%
0.00%0.0%
Q4 2014$2,928,000
+5.4%
57,586
-18.0%
0.00%0.0%
Q3 2014$2,779,000
+53.6%
70,230
+67.2%
0.00%
+50.0%
Q2 2014$1,809,000
+2219.2%
42,004
+2050.7%
0.00%
Q1 2014$78,000
+50.0%
1,953
+3.1%
0.00%
Q4 2013$52,000
+15.6%
1,894
-4.0%
0.00%
Q3 2013$45,000
-94.2%
1,973
-95.5%
0.00%
-100.0%
Q2 2013$779,00043,9980.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 564,102$42,184,00014.63%
Fairmount Funds Management LLC 387,400$28,970,0009.55%
Soleus Capital Management, L.P. 318,275$23,801,0002.38%
Darwin Global Management, Ltd. 166,190$12,428,0001.90%
Paradigm Biocapital Advisors LP 75,507$5,646,0001.61%
ARMISTICE CAPITAL, LLC 1,056,000$78,968,0001.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 150,000$11,217,0001.29%
Portland Global Advisors LLC 75,869$5,673,0000.95%
FARALLON CAPITAL MANAGEMENT LLC 1,573,829$117,691,0000.59%
Yorktown Management & Research Co Inc 10,400$778,0000.52%
View complete list of ENANTA PHARMACEUTICALS INC shareholders